In support of a program to develop a treatment for diseases resulting from an imbalance in dopamine levels, two drug candidates, 1 and 2, were prepared in stable isotope and C‐14 labeled forms. Both compounds contained an aminothiazole ring, and the C‐14 label was introduced into the ring using KS14CN. However, the use of KS14CN to form [14C]‐2 gave poor results; therefore, benzoyl [14C]isothiocyanate was used instead, which led to a much improved yield. The stable isotope labeled forms were prepared with the label in the side chain from [2H5]ethyl iodide for [2H5]‐1 and from 1‐[13C]methyl [15N2]pyrazole[13C]carboxaldehyde, which was prepared in turn from [carbonyl‐13C]DMF, [15N2]hydrazine sulfate, and [13C]methyliodide for [13C2, 15N2]‐2. Copyright © 2012 John Wiley & Sons, Ltd.